S184: EVALUATING TECLISTAMAB IN PATIENTS WITH RELAPSED/ REFRACTORY MULTIPLE MYELOMA FOLLOWING EXPOSURE TO OTHER B-CELL MATURATION ANTIGEN (BCMA)-TARGETED AGENTS. (23rd June 2022) - Touzeau, C.; Krishnan, A.; Moreau, P.; Perrot, A.; Usmani, S. Z.; Manier, S.; Cavo, M.; Martinez-Chamorro, C.; Nooka, A.; Martin, T.; Karlin, L.; Leleu, X.; et al.